# Milestone Scientific Inc.: Form 10-Q for the period ended Sep 30, 2014

- Company: [Milestone Scientific Inc.](/companies/mlss.md) (CIK 855683)
- Form: 10-Q
- Filed: 2014-11-13
- Accepted by EDGAR: Nov 13, 2014, 17:16 ET
- Period: 2014-09-30
- Accession: 0001564590-14-005667
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/855683/000156459014005667/mlss-10q_20140930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/855683/000156459014005667/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2014-07-01 to 2014-09-30 | $2.5m | us-gaap:SalesRevenueGoodsNet |
| Revenue | 9 months, 2014-01-01 to 2014-09-30 | $7.7m | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months, 2014-07-01 to 2014-09-30 | $829.5k | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months, 2014-01-01 to 2014-09-30 | $2.6m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2014-07-01 to 2014-09-30 | $1.7m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2014-01-01 to 2014-09-30 | $5.0m | us-gaap:GrossProfit |
| Research and development | 3 months, 2014-07-01 to 2014-09-30 | $29.4k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2014-01-01 to 2014-09-30 | $74.3k | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2014-07-01 to 2014-09-30 | $1.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2014-01-01 to 2014-09-30 | $4.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2014-07-01 to 2014-09-30 | −$162.2k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2014-01-01 to 2014-09-30 | $214.5k | us-gaap:OperatingIncomeLoss |
| Net income | 3 months, 2014-07-01 to 2014-09-30 | −$358.5k | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2014-01-01 to 2014-09-30 | −$333.1k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2014-07-01 to 2014-09-30 | −$0.02 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2014-01-01 to 2014-09-30 | −$0.02 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2014-07-01 to 2014-09-30 | −$0.02 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2014-01-01 to 2014-09-30 | −$0.02 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2014-07-01 to 2014-09-30 | 21,189,245 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2014-01-01 to 2014-09-30 | 19,621,471 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2014-01-01 to 2014-09-30 | −$3.4k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2014-01-01 to 2014-09-30 | $66.1k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2014-09-30 | $781.5k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2014-09-30 | $15.6m | us-gaap:AssetsCurrent |
| Total assets | at 2014-09-30 | $17.3m | us-gaap:Assets |
| Current liabilities | at 2014-09-30 | $2.0m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2014-09-30 | $15.3m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/855683/000156459014005667/mlss-10q_20140930.htm

Filed Nov 13, 2014.
Source: SEC EDGAR, the filing index for accession 0001564590-14-005667. Last ingested by Listed: Nov 14, 2026, 11:14 ET. No prices; not investment advice.
